Selbyville, Delaware, June 05, 2023 (GLOBE NEWSWIRE) --
Infectious Disease Diagnostics Market size will be worth USD 40 billion by 2032. The growing prevalence of infectious diseases across the globe will influence the demand for infectious disease diagnostics.
In recent years, the emergence of several recurring infection outbreaks, including the SARS-CoV-2, HIV-1, HIV-2, and ME respiratory syndrome coronavirus has spurred the need for early disease detection. The rise in international travel has also substantially contributed to the spread of vector-borne diseases globally. The growing support from CDC for the effective disinfection and sterilization of infection control commodities by healthcare professionals in ambulatory care and hospitals will also add to the market gains.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5597
However, the limitations in the number of qualified healthcare workers in hospitals, clinics, and long-term care homes may pose a barrier for the infectious disease diagnostics need. Lately, healthcare facilities are facing challenges in providing necessary services, further leading to higher rates of burnout and overworked employees. Lower access to care, longer wait times for appointments and poorer care quality are other factors limiting the market expansion.
Rising adoption of instruments
The infectious disease diagnostics market size from instruments will witness 5.5% CAGR from 2023-2032. In recent years, the demand for accurate, quick, and affordable diagnostic tests has significantly soared. The rising frequency of new infectious diseases, including COVID-19 along with the surging global emphasis on prevention as well as control of such diseases is also adding to the adoption of infectious disease diagnostic tools.
Browse key industry insights spread across 380 pages with 348 market data tables & 18 figures & charts from the report, “Infectious Disease Diagnostics Market Size By Product (Instruments, Reagents, kits & Consumables, Services), By Technology (Clinical Microbiology, Polymerase Chain Reaction (PCR), In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Immunodiagnostics), By Application (COVID-19, Gastrointestinal Tract Infections, Respiratory Diseases, Sexually Transmitted Infections, Tuberculosis, Hospital Acquired Infection, Mosquito-borne Diseases), By End-use (Hospitals, Clinics, Diagnostics Laboratories, Research Institutes) Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” In detail along with the table of contents:
https://www.gminsights.com/industry-analysis/infectious-disease-diagnostics-market
Increasing burden of HAIs
Infectious disease diagnostics market size from healthcare-associated infections (HAIs) may witness 6.2% CAGR from 2023-2032. Urinary tract infections, respiratory pneumonia, bacteremia, surgical site wound infections, and gastrointestinal and skin infections are some major HAIs affecting the patients in the healthcare settings. According to WHO, out of each 100 patients admitted to acute care in hospitals, nearly 15 in low- and middle-income countries as well as 7 in high-income countries are infected by at least on HAI during their hospital stay.
APAC to lead the regional landscape
Asia Pacific infectious disease diagnostics industry share had reached more than USD 5 billion in 2022 due to the increasing focus on the development of new products by numerous industry participants and the surge in regulatory approvals for manufacturing excellent quality products. The rise in the number of government programmes has added to increased awareness regarding infectious disease diagnostics. The growing burden of infectious diseases will also push the regional market progress.
Secure a copy of the premium research report @ https://www.gminsights.com/securecheckout/paymenta/5597?gmpaycod=sugmp
Infectious Disease Diagnostics Market Leaders
Abbott Laboratories, BioMerieus SA, Becton Dickinson and Company, Bio-Rad Laboratories, Hologic Inc., Danaher Corporation, F Hoffman-La Roche, Qiagen Inc., Siemens Healthineers, and Thermo Fisher Scientific Inc. are some of the renowned infectious disease diagnostics companies. These industry players are working on collaborative strategies, such as mergers, partnerships and acquisitions to reinforce their market presence.
Partial Table of Contents (ToC) of the report:
Chapter 2 Executive Summary
2.1 Infectious disease diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends (USD Milion)
2.1.2 Product trends
2.1.3 Technology trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends (USD Milion)
Chapter 3 Infectious Disease Diagnostics Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing incidence of infectious diseases
3.2.1.2 Rise in demand for point-of-care diagnostic testing
3.2.1.3 Technological advancement in infectious disease diagnostics
3.2.1.4 Rise in awareness regarding early diagnosis detection
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled professionals
3.2.2.2 Lack of awareness regarding infection control and prevention
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By application
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
